Begin Main Content Area

​Prescribing Suggestions for Hydroxychloroquine

Suggestion for Board of Medicine and Osteopathic Medicine for Prescribers: 

In response to COVID-19 and potential shortages of medications that may be effective against the virus such as hydroxychloroquine, prescribers should include the patient’s diagnosis on the prescription. If written for a COVID-19 diagnosis, the diagnosis has been confirmed by a positive test result and documented on the prescription. Smaller quantities of hydroxychloroquine should be prescribed for COVID-19 patients when appropriate to prevent potential shortages. 

For Board of Pharmacy for Pharmacists: 

In response to COVID-19 and potential shortages of medications that may be effective against the virus such as hydroxychloroquine, pharmacists should verify the patient is confirmed COVID-19 positive before dispensing. Patients established on therapy or utilizing the medication for other diagnoses (e.g. Lupus or Rheumatoid Arthritis) should be able to continue to access without diagnosis verification. Smaller quantities of hydroxychloroquine should be dispensed to COVID-19 patients when appropriate to prevent potential shortages.